Packaging & Delivery System Integrity Tests

This section pertains to the fit of any component intended to seal or effect container closure in contact with a container. Packaging and delivery system integrity refers to the ability of a packaging and delivery system to keep the product contents in and prevent detrimental environmental contaminants from entering. All closures must ensure adequate system integrity, which is crucial for maintaining product quality. Hence, all systems within the scope of this chapter need to pass an appropriate functional suitability assessment of packaging and delivery system integrity.  

Cutting-Edge Packaging and Delivery System Integrity Testing

The packaging and delivery system is considered acceptable if all test samples meet the maximum allowable leakage limit required for the product. This ensures that there is no risk to the microbiological quality of the product and that there is no significant effect on the physical and chemical properties of the product. 

Assured Quality: Advanced Integrity Testing

The Package/Delivery System Integrity Tests adopt two definitions that are key concepts of USP 1207 Package Integrity Evaluation – Sterile Products:

Gateway Analytical - Analysis Solutions

Early-Phase Development

Comprehensive packages designed to navigate clinical & regulatory complexities of parenteral product-package and container-closure development, from concept to market readiness.

Container Closure
Integrity Testing

Quantitative, non-destructive, deterministic leak detection technologies for products stored in vials, syringes, cartridges, flexible containers, and bottles.

Particulate
Analysis

Multi-analytical methods to count, size, and characterize visible and subvisible particulate matter in pharmaceuticals, disposable containers, single-use systems, raw materials, and medical devices.

Medical Device
Analysis

Rigorous studies focused on enumerating particulate matter and identifying potential chemical compounds that could migrate from medical devices into the environment or directly impact patient health.

Extractables
& Leachables

Studies aimed at identifying potentially harmful compounds in manufacturing components and final containers to ensure the safety and efficacy of pharmaceutical products.

Covering every stage of the drug development journey with our state-of-the-art, FDA-inspected, cGMP-compliant facilities designed to minimize bottlenecks and maximize success.